##analysisDate=2017-09-07-12-51-00000
##analyzedBy=RingStudy Site F
##exportDate=2017-11-08-11-19-05000
##analysisName=Site F-092-Sample 2-F-SE17-0229-Ring_Study-OCAv3_REPEAT
##workflowName=Oncomine Comprehensive v3 - w2.1 - DNA and Fusions - Single Sample
##sampleNames=SE17-0229_v1:SE17-0229_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=2458
##filterInCount=90
##filteredOutCount=2368
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:156846233	G/A	G	SNV		NTRK1	exonic	1								48.28	p.(=)		29	G=0.5172, A=0.4828		Present				+	14	NM_002529.3	c.1674G>A	synonymous	0.77				Protein kinase domain,Protein tyrosine kinase	rs6334		0.213 (ref)	0.2194	0.1432	0.1936	YES	ATP binding,Ras protein signal transduction,activation of MAPKK activity,activation of adenylate cyclase activity,activation of phospholipase C activity,axonogenesis involved in innervation,cell differentiation,developmental programmed cell death,endosome,integral to plasma membrane,multicellular organismal development,negative regulation of cell proliferation,negative regulation of neuron apoptosis,nerve growth factor binding,nerve growth factor receptor activity,nerve growth factor receptor signaling pathway,nervous system development,neurotrophin binding,nucleotide binding,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of NF-kappaB transcription factor activity,positive regulation of Ras GTPase activity,positive regulation of Ras protein signal transduction,positive regulation of angiogenesis,positive regulation of neuron projection development,positive regulation of programmed cell death,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,receptor activity,small GTPase mediated signal transduction,sympathetic nervous system development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Amitriptyline,Imatinib		0.00001	123.969	G=15, A=14		G=8/7, A=12/2	1	
chr2:29436854	G/A	G	SNV		ALK	exonic	1								5.68	p.His1247Tyr		88	G=0.9432, A=0.0568		Present				-	24	NM_004304.4	c.3739C>T	missense	2.67	0.0	83.0	1.0	MAM domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.05532	12.5708	G=83, A=5		G=47/36, A=4/1	2	
chr2:29443671	G/A	G	SNV		ALK	exonic	1								7.69	p.(=)		39	G=0.9231, A=0.0769		Present				-	23	NM_004304.4	c.3546C>T	synonymous	-0.53				MAM domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.0412	13.8515	G=36, A=3		G=24/12, A=1/2	1	
chr2:29445458	G/T	G	SNV		ALK	exonic	1								50.00	p.(=)		26	G=0.5, T=0.5		Present				-	21	NM_004304.4	c.3375C>A	synonymous	-1.83				MAM domain,Protein kinase domain,Protein tyrosine kinase	rs3795850		0.395 (ref)	0.2058	0.2519	0.2214	YES	ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	113.384	G=13, T=13		G=6/7, T=9/4	1	
chr2:47637391	G/A	G	SNV		MSH2	exonic	1								5.88	p.(=)		51	G=0.9412, A=0.0588		Present				+	3	NM_000251.2	c.525G>A	synonymous	0.33				MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV	rs63750705,rs63751067							ADP binding,ATP binding,ATP catabolic process,ATPase activity,B cell differentiation,B cell mediated immunity,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,MutSbeta complex,Y-form DNA binding,cell cycle arrest,centromeric DNA binding,damaged DNA binding,determination of adult lifespan,dinucleotide insertion or deletion binding,dinucleotide repeat insertion binding,double-strand break repair,double-strand/single-strand DNA junction binding,double-stranded DNA binding,enzyme binding,four-way junction DNA binding,germ cell development,guanine/thymine mispair binding,in utero embryonic development,intra-S DNA damage checkpoint,isotype switching,loop DNA binding,magnesium ion binding,maintenance of DNA repeat elements,male gonad development,meiotic gene conversion,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,negative regulation of neuron apoptosis,negative regulation of reciprocal meiotic recombination,nuclear chromosome,nucleotide binding,nucleus,oxidative phosphorylation,oxidized purine DNA binding,positive regulation of helicase activity,postreplication repair,protein C-terminus binding,protein binding,protein homodimerization activity,protein kinase binding,response to UV-B,response to X-ray,response to amino acid stimulus,response to drug,response to organic cyclic compound,single guanine insertion binding,single thymine insertion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments,spermatogenesis			0.07766	11.0982	G=48, A=3		G=25/23, A=1/2	1	
chr2:48030632	G/T	G	SNV		MSH6	exonic	1								39.22	p.(=)		51	G=0.6078, T=0.3922		Present				+	5	NM_000179.2	c.3246G>T	synonymous	0.33				MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain	rs3136351		0.002	0.0053	0.0011	0.0039		ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments		probable-non-pathogenic	0.00001	153.021	G=31, T=20		G=10/21, T=9/11	2	
chr3:12632368	C/T	C	SNV		RAF1	exonic	1								5.80	p.(=)		69	C=0.942, T=0.058		Present				-	12	NM_002880.3	c.1299G>A	synonymous	2.62				Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain								ATP binding,MAP kinase kinase kinase activity,MAPKKK cascade,Ras GTPase binding,Ras protein signal transduction,activation of MAPKK activity,apoptotic process,axon guidance,blood coagulation,cell proliferation,cytoplasm,cytoskeleton organization,cytosol,epidermal growth factor receptor signaling pathway,heart development,insoluble fraction,insulin receptor signaling pathway,metal ion binding,mitochondrial outer membrane,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of cell proliferation,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of protein complex assembly,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,regulation of Rho protein signal transduction,regulation of apoptotic process,regulation of cell differentiation,regulation of cell motility,response to hypoxia,signal transduction,small GTPase mediated signal transduction,synaptic transmission,wound healing	Sorafenib		0.0636	11.9652	C=65, T=4		C=35/30, T=2/2	1	
chr3:37053568	A/G	A	SNV		MLH1	exonic	1								53.90	p.Ile219Val		141	A=0.461, G=0.539		Present				+	8	NM_000249.3	c.655A>G	missense	2.21	0.17	29.0	0.018	DNA mismatch repair protein,Histidine kinase-	rs1799977		0.172	0.3202	0.0921	0.243	YES	ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,MutLalpha complex,MutLbeta complex,MutSalpha complex binding,cell cycle,cellular response to organic cyclic compound,chiasma,double-strand break repair via nonhomologous end joining,guanine/thymine mispair binding,isotype switching,male germ cell nucleus,male meiosis chromosome segregation,meiotic metaphase I plate congression,mismatch repair,mismatched DNA binding,negative regulation of mitotic recombination,nuclear-transcribed mRNA poly(A) tail shortening,nucleus,oogenesis,pachytene,protein binding,reciprocal meiotic recombination,resolution of meiotic recombination intermediates,response to drug,response to hypoxia,response to toxin,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,spermatogenesis,spindle midzone assembly involved in meiosis,synaptonemal complex		non-pathogenic,probable-non-pathogenic	0.00001	732.558	A=65, G=76		A=32/33, G=41/35	1	
chr3:47125385	A/A	G	SNV		SETD2	exonic	1								99.45	p.Pro1962Leu		182	G=0.0055, A=0.9945		Present				-	12	NM_014159.6	c.5885C>T	missense	0.33	0.06	98.0	0.0	SET domain,WW domain	rs4082155		0.496 (ref)	0.4338	0.2862	0.4713	YES	DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.00001	2686.06	G=1, A=181		G=1/0, A=102/79	3	
chr3:47139510	T/C	T	SNV		SETD2	exonic	1								6.98	p.Asn1693Asp		43	T=0.9302, C=0.0698		Present				-	9	NM_014159.6	c.5077A>G	missense	2.22	0.0	23.0	0.999	SET domain,WW domain								DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.05168	12.867	T=40, C=3		T=23/17, C=2/1	4	
chr3:47162661	G/G	A	SNV		SETD2	exonic	1								100.00	p.(=)		30	A=0.0, G=1.0		Present				-	3	NM_014159.6	c.3465T>C	synonymous	-0.59				SET domain,WW domain	rs6767907		0.316 (ref)	0.4088	0.2506	0.3552	YES	DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.00001	429.02	A=0, G=30		A=0/0, G=9/21	1	
chr3:142178144	C/T	C	SNV		ATR	exonic	1								49.69	p.Arg2425Gln		318	C=0.5031, T=0.4969		Present				-	43	NM_001184.3	c.7274G>A	missense	-2.53	0.5	43.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2229032		0.12 (ref)	0.1578	0.0881	0.1342	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	1489.67	C=160, T=158		C=78/82, T=82/76	1	
chr3:142224105	C/T	C	SNV		ATR	exonic	1								6.82	p.Gly1691Glu		44	C=0.9318, T=0.0682		Present				-	29	NM_001184.3	c.5072G>A	missense	2.59	0.0	98.0	1.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain								ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.05457	12.6302	C=41, T=3		C=20/21, T=2/1	2	
chr3:142277536	A/G	A	SNV		ATR	exonic	1								47.67	p.(=)		258	A=0.5233, G=0.4767		Present				-	8	NM_001184.3	c.1815T>C	synonymous	0.12				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2227929		0.349 (ref)	0.414	0.2127	0.3458	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	1107.93	A=135, G=123		A=62/73, G=57/66	1	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		837	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	12574.1	G=0, A=837		G=0/0, A=456/381	1	
chr4:55602765	G/C	G	SNV		KIT	exonic	1								60.00	p.(=)		30	G=0.4, C=0.6		Present				+	18	NM_000222.2	c.2586G>C	synonymous	-0.49				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs3733542		0.144 (ref)	0.1253	0.3252	0.1931	YES	ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	181.532	G=12, C=18		G=6/6, C=10/8	1	
chr4:153332627	T/C	T	SNV		FBXW7	exonic	1								6.56	p.Glu110Gly		61	T=0.9344, C=0.0656		Present				-	2	NM_033632.3	c.329A>G	missense	2.03	0.0	98.0	0.037	F-box domain,WD domain								Golgi apparatus,SCF ubiquitin ligase complex,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,cellular response to UV,cytoplasm,endoplasmic reticulum,interspecies interaction between organisms,lipid homeostasis,negative regulation of DNA endoreduplication,negative regulation of Notch signaling pathway,negative regulation of SREBP-mediated signaling pathway,negative regulation of hepatocyte proliferation,negative regulation of triglyceride biosynthetic process,nucleolus,nucleoplasm,nucleus,perinuclear region of cytoplasm,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor-activated receptor activity,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,protein binding,protein complex,protein stabilization,protein ubiquitination,regulation of lipid storage,regulation of protein localization,response to DNA damage stimulus,sequence-specific DNA binding transcription factor activity,sister chromatid cohesion,vasculature development			0.06277	12.0226	T=57, C=4		T=36/21, C=3/1	1	
chr5:1294086	C/T	C	SNV		TERT	exonic	1								54.36	p.(=)		195	C=0.4564, T=0.5436		Present				-	2	NM_198253.2	c.915G>A	synonymous	-1.35					rs2736098		0.213 (ref)	0.2597	0.1051	0.2075	YES	DNA binding,DNA strand elongation,PML body,anti-apoptosis,chromosome,chromosome, telomeric region,cytoplasm,metal ion binding,nuclear telomere cap complex,nucleolus,nucleoplasm,nucleotidyltransferase activity,nucleus,protein binding,protein homodimerization activity,replicative senescence,telomerase activity,telomerase holoenzyme complex,telomere formation via telomerase,telomere maintenance,telomere maintenance via telomerase,telomeric DNA binding,telomeric RNA binding,telomeric template RNA reverse transcriptase activity,transferase activity		non-pathogenic	0.00001	1053.48	C=89, T=106		C=45/44, T=44/62	3	
chr5:67588148	G/A	G	SNV		PIK3R1	exonic	1								41.18	p.Met326Ile		51	G=0.5882, A=0.4118		Present				+	8	NM_181523.2	c.978G>A	missense	1.5	0.42	10.0	0.0	RhoGAP domain,SH2 domain,SH3 domain	rs3730089		0.218 (ref)	0.1645	0.3822	0.2383	YES	1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol		0.00001	164.72	G=30, A=21		G=14/16, A=7/14	1	
chr5:176516631	G/A	G	SNV		FGFR4	exonic	1								54.55	p.Val10Ile		198	G=0.4545, A=0.5455		Present				+	2	NM_213647.1	c.28G>A	missense	-0.41	0.35	29.0	0.0	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs1966265		0.249 (ref)	0.227	0.0611	0.1708	YES	ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	1080.34	G=90, A=108		G=49/41, A=53/55	5	
chr5:176520243	G/A	G	SNV		FGFR4	exonic	1								54.55	p.Gly388Arg		88	G=0.4545, A=0.5455		Present				+	9	NM_213647.1	c.1162G>A	missense	2.23	0.0	125.0	0.998	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs351855		0.303 (ref)	0.3006	0.1287	0.2423	YES	ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin	pathogenic	0.00001	448.481	G=40, A=48		G=16/24, A=15/33	3	
chr5:176522554	G/A	G	SNV		FGFR4	exonic	1								7.32	p.Glu551Lys		41	G=0.9268, A=0.0732		Present				+	13	NM_213647.1	c.1651G>A	missense	2.48	0.0	56.0	1.0	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.04623	13.3505	G=38, A=3		G=14/24, A=1/2	2	
chr6:41903782	AG/CA	AG	MNV		CCND3	exonic	2								29.91	p.Ser259Ala		224	AG=0.7009, CA=0.2991		Present				-	5	NM_001760.4	c.774_775delCTinsTG	synonymous, missense	-0.25,-2.53	0.59	99.0	0.0	Cyclin	rs1051130,rs3218102		0.035,0.415	0.4535	0.2238	0.3757	YES	T cell proliferation,cell division,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,membrane,nucleus,positive regulation of cyclin-dependent protein kinase activity,positive regulation of protein phosphorylation,protein binding,protein kinase binding,regulation of cell cycle,signal transduction			0.00001	454.299	AG=157, CA=67		AG=79/78, CA=29/38	1	
chr6:152129077	T/C	T	SNV		ESR1	exonic	1								70.83	p.(=)		48	T=0.2917, C=0.7083		Present				+	2	NM_001122740.1	c.30T>C	synonymous	-1.28				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs2077647		0.432 (ref)	0.4769	0.4828	0.4789	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	356.765	T=14, C=34		T=8/6, C=24/10	1	
chr6:152201875	C/C	T	SNV		ESR1	exonic	1								100.00	p.(=)		55	T=0.0, C=1.0		Present				+	4	NM_001122740.1	c.729T>C	synonymous	0.22				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs4986934		0.018 (ref)	0.04	0.0082	0.0292	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	773.73	T=0, C=55		T=0/0, C=29/26	1	
chr6:152265522	G/C	G	SNV		ESR1	exonic	1								73.53	p.(=)		34	G=0.2647, C=0.7353		Present				+	5	NM_001122740.1	c.975G>C	synonymous	-0.42				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs1801132		0.262 (ref)	0.2257	0.1074	0.1856	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	281.854	G=9, C=25		G=5/4, C=17/8	1	
chr7:6026775	C/C	T	SNV		PMS2	exonic	1								100.00	p.Lys541Glu		418	T=0.0, C=1.0		Present				-	11	NM_000535.5	c.1621A>G	missense	0.74	1.0	56.0	0.0	DNA mismatch repair protein,Histidine kinase-	rs2228006		0.121 (ref)	0.1543	0.0815	0.1296	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester		0.00001	6256.52	T=0, C=418		T=0/0, C=170/248	4	
chr7:6026988	G/A	G	SNV		PMS2	exonic	1								52.02	p.Pro470Ser		842	G=0.4798, A=0.5202		Present				-	11	NM_000535.5	c.1408C>T	missense	0.39	0.51	74.0	0.002	DNA mismatch repair protein,Histidine kinase-	rs1805321		0.394 (ref)	0.4209	0.2819	0.3738	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic	0.00001	4185.6	G=404, A=438		G=204/200, A=199/239	2	
chr7:6036980	C/C	G	SNV		PMS2	exonic	1								100.00	p.(=)		195	G=0.0, C=1.0		Present				-	7	NM_000535.5	c.780C>G	synonymous	-5.63				DNA mismatch repair protein,Histidine kinase-	rs1805319		0.157 (ref)	0.1852	0.1586	0.1762	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic	0.00001	2959.74	G=0, C=195		G=0/0, C=86/109	2	
chr7:55233089	C/T	C	SNV		EGFR	exonic	1								38.10	p.(=)		21	C=0.619, T=0.381		Present				+	15	NM_005228.3	c.1839C>T	synonymous	0.33				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs17290169		0.041 (ref)	0.0595	0.0552	0.058	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	55.8318	C=13, T=8		C=7/6, T=5/3	2	
chr7:55249063	A/A	G	SNV		EGFR,EGFR-AS1	exonic, exonic_nc	1								100.00	p.(=)		33	G=0.0, A=1.0		Present				+, -	20	NM_005228.3, NR_047551.1	c.2361G>A	synonymous	2.8				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1050171		0.418 (ref)	0.3962	0.4226	0.4576	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	483.349	G=0, A=33		G=0/0, A=11/22	1	
chr7:55266417	C/C	T	SNV		EGFR	exonic	1								100.00	p.(=)		53	T=0.0, C=1.0		Present				+	23	NM_005228.3	c.2709T>C	synonymous	-1.92				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1140475		0.095 (ref)	0.1267	0.0801	0.1109	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	739.757	T=0, C=53		T=0/0, C=25/28	1	
chr7:55266487	C/T	C	SNV		EGFR	exonic	1								5.66	p.(=)		53	C=0.9434, T=0.0566		Present				+	23	NM_005228.3	c.2779C>T	synonymous	0.67				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs374672672			0.0	2.0E-4	1.0E-4		AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.08519	10.6963	C=50, T=3		C=23/27, T=2/1	2	
chr7:116435768	C/T	C	SNV		MET	exonic	1								49.77	p.(=)		1320	C=0.5023, T=0.4977		Present				+	20	NM_001127500.1	c.3912C>T	synonymous	-3.37				IPT/TIG domain,Plexin repeat,Protein kinase domain,Protein tyrosine kinase,Sema domain	rs41736		0.372 (ref)	0.4243	0.1041	0.3235	YES	ATP binding,axon guidance,basal plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,hepatocyte growth factor receptor signaling pathway,hepatocyte growth factor-activated receptor activity,integral to membrane,integral to plasma membrane,multicellular organismal development,nucleotide binding,plasma membrane,protein binding,protein tyrosine kinase activity,receptor activity,signal transduction	1-(2-NITROPHENYL)SULFONYL-1H-PYRROLO3,2-BPYRIDINE-6-CARBOXAMIDE,1-(4-fluorophenyl)-N-3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenyl-2-oxo-1,2-dihydropyridine-3-carboxamide,2-(4-fluorophenyl)-N-{3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenylcarbamoyl}acetamide,3-(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine,3-3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-ylphenol,6-{6-(1-methyl-1H-pyrazol-4-yl)1,2,4triazolo4,3-bpyridazin-3-ylsulfanyl}quinoline,K-252a,N-(3-chlorophenyl)-N-methyl-2-oxo-3-(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl-2H-indole-5-sulfonamide,N-({4-(2-aminopyridin-4-yl)oxy-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide		0.00001	6123.23	C=663, T=657		C=358/305, T=357/300	1	
chr7:140449150	T/C	T	SNV		BRAF	exonic	1								30.56	p.(=)		36	T=0.6944, C=0.3056		Present				-	16	NM_004333.4	c.1929A>G	synonymous	-0.01				C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain	rs9648696		0.28 (ref)	0.1463	0.3409	0.32	YES	ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib		0.00001	82.6973	T=25, C=11		T=11/14, C=1/10	2	
chr8:90995019	C/T	C	SNV		NBN	exonic	1								65.33	p.(=)		1044	C=0.3467, T=0.6533		Present				-	2	NM_002485.4	c.102G>A	synonymous	-0.39				BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs1063045		0.35 (ref)	0.3147	0.3103	0.3132	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	7485.02	C=362, T=682		C=220/142, T=393/289	1	
chr8:128750604	CCAG/C	CCAG	INDEL		MYC	exonic	3					HS	COSM4704353		6.25	p.Gln48del		80	CCAG=0.9375, C=0.0625		Present				+	2	NM_002467.4	c.154_156delCAG	nonframeshiftDeletion	1.35,2.65,2.14,-0.04				Helix-loop-helix DNA-binding domain,Myc amino-terminal region,Myc leucine zipper domain	rs61752959		0.01	2.0E-4	2.0E-4	2.0E-4	YES	DNA binding,E-box binding,MAPKKK cascade,branching involved in ureteric bud morphogenesis,canonical Wnt receptor signaling pathway,cell cycle arrest,cellular iron ion homeostasis,cellular response to UV,cellular response to drug,chromatin remodeling,chromosome organization,energy reserve metabolic process,fibroblast apoptosis,negative regulation of apoptotic process,negative regulation of cell division,negative regulation of fibroblast proliferation,negative regulation of monocyte differentiation,negative regulation of stress-activated MAPK cascade,negative regulation of transcription from RNA polymerase II promoter,nucleolus,nucleoplasm,nucleus,oxygen transport,positive regulation of DNA biosynthetic process,positive regulation of cell proliferation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of mesenchymal cell proliferation,positive regulation of metanephric cap mesenchymal cell proliferation,positive regulation of response to DNA damage stimulus,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex,protein complex binding,regulation of telomere maintenance,repressing transcription factor binding,response to DNA damage stimulus,response to drug,response to gamma radiation,response to growth factor stimulus,sequence-specific DNA binding transcription factor activity,spindle,transcription factor binding			0.06656	11.7679	CCAG=75, C=5		CCAG=17/58, C=2/3	2	
chr9:21970916	C/T	C	SNV		CDKN2A	exonic	1								56.43	p.Ala148Thr		886	C=0.4357, T=0.5643		Present				-	2	NM_000077.4	c.442G>A	missense	0.4	0.0	58.0	0.351	Cyclin-dependent kinase inhibitor 2a p19Arf N-terminus	rs3731249		0.012 (ref)	0.0321	0.0039	0.0225	YES	G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,NF-kappaB binding,Ras protein signal transduction,cell aging,cell cycle arrest,cell cycle checkpoint,cyclin-dependent protein kinase inhibitor activity,cytoplasm,cytosol,epidermis development,induction of apoptosis,mitotic cell cycle,negative regulation of NF-kappaB transcription factor activity,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of cell-matrix adhesion,negative regulation of cyclin-dependent protein kinase activity,negative regulation of mammary gland epithelial cell proliferation,negative regulation of phosphorylation,negative regulation of transcription, DNA-dependent,nucleolus,nucleoplasm,nucleus,positive regulation of apoptosis involved in mammary gland involution,positive regulation of cellular senescence,positive regulation of macrophage apoptosis,positive regulation of smooth muscle cell apoptosis,protein binding,protein kinase binding,rRNA transcription,regulation of nucleocytoplasmic transport,replicative senescence,senescence-associated heterochromatin focus,senescence-associated heterochromatin focus assembly,sequence-specific DNA binding transcription factor activity			0.00001	5018.08	C=386, T=500		C=185/201, T=251/249	1	
chr9:87342735	G/A	G	SNV		NTRK2	exonic	1								5.45	p.(=)		55	G=0.9455, A=0.0545		Present				+	11	NM_006180.3	c.1020G>A	synonymous	2.8				Immunoglobulin I-set domain,Leucine rich repeat N-terminal domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,activation of adenylate cyclase activity,brain-derived neurotrophic factor binding,brain-derived neurotrophic factor receptor signaling pathway,brain-derived neurotrophic factor-activated receptor activity,central nervous system neuron development,cerebral cortex development,integral to plasma membrane,learning,membrane,multicellular organismal development,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nervous system development,neuron differentiation,neuron migration,neurotrophin-3 binding,neurotrophin-4/5 binding,nucleotide binding,positive regulation of MAPKKK cascade,positive regulation of axonogenesis,positive regulation of cell proliferation,positive regulation of gene expression,positive regulation of neuron projection development,positive regulation of phosphatidylinositol 3-kinase cascade,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of Rac GTPase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Amitriptyline		0.09305	10.313	G=52, A=3		G=20/32, A=1/2	2	
chr9:135786025	G/A	G	SNV		TSC1	exonic	1								3.57	p.Pro399Leu		56	G=0.963, A=0.037		Present				-	12	NM_000368.4	c.1196C>T	missense	0.8	0.52	98.0	0.0	Hamartin protein	rs118203502							GTPase activating protein binding,GTPase regulator activity,TSC1-TSC2 complex,actin filament,activation of Rho GTPase activity,cardiac muscle cell differentiation,cell cortex,cell cycle arrest,cell projection organization,cell-matrix adhesion,cerebral cortex development,chaperone binding,cytoplasm,cytosol,embryo development,growth cone,hippocampus development,insulin receptor signaling pathway,kidney development,lamellipodium,membrane,membrane fraction,microsome,myelination,negative regulation of TOR signaling cascade,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of translation,nervous system development,neural tube closure,positive regulation of focal adhesion assembly,potassium ion transport,protein N-terminus binding,protein binding,protein complex,protein heterooligomerization,protein stabilization,rRNA export from nucleus,regulation of actin cytoskeleton organization,regulation of cell-matrix adhesion,regulation of phosphoprotein phosphatase activity,regulation of protein kinase activity,regulation of stress fiber assembly,regulation of translation,response to insulin stimulus,synapse organization			0.06625	11.788	G=52, A=2		G=29/23, A=1/1	4	
chr9:139391636	G/A	G	SNV		NOTCH1	exonic	1								54.21	p.(=)		273	G=0.4579, A=0.5421		Present				-	34	NM_017617.3	c.6555C>T	synonymous	-0.09				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs2229974		0.305 (ref)	0.4467	0.3639	0.4187	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	1463.24	G=125, A=148		G=59/66, A=82/66	1	
chr9:139397707	G/A	G	SNV		NOTCH1	exonic	1								61.76	p.(=)		68	G=0.3824, A=0.6176		Present				-	27	NM_017617.3	c.5094C>T	synonymous	-0.82				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs10521		0.417 (ref)	0.3534	0.4829	0.408	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	439.868	G=26, A=42		G=15/11, A=20/22	1	
chr9:139413908	C/T	C	SNV		MIR4673,NOTCH1	exonic, downstream	1								43.38	p.(=)		551	C=0.5662, T=0.4338		Present				-	5	NM_017617.3, NR_039820.1	c.852G>A	synonymous	-2.83				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs2229975		0.101	0.1355	0.1031	0.1251	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	2057.11	C=312, T=239		C=115/197, T=89/150	1	
chr9:139418260	A/G	A	SNV		NOTCH1	exonic	1								44.02	p.(=)		184	A=0.5598, G=0.4402		Present				-	3	NM_017617.3	c.312T>C	synonymous	-1.16				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs4489420		0.293 (ref)	0.4711	0.1191	0.3913	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	699.444	A=103, G=81		A=58/45, G=42/39	1	
chr11:108159756	G/A	G	SNV		ATM	exonic	1								11.54	p.Ala1388Thr		26	G=0.8846, A=0.1154		Present				+	28	NM_000051.3	c.4162G>A	missense	2.5	0.0	58.0	0.836	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase								1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle			0.03609	14.4259	G=23, A=3		G=10/13, A=2/1	1	
chr11:108168090	T/C	T	SNV		ATM	exonic	1								7.14	p.(=)		42	T=0.9286, C=0.0714		Present				+	33	NM_000051.3	c.4986T>C	synonymous	0.32				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase								1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle			0.04891	13.1062	T=39, C=3		T=6/33, C=2/1	1	
chr11:108183167	A/G	A	SNV		ATM	exonic	1								96.47	p.Asn1983Ser		85	A=0.0353, G=0.9647		Present				+	40	NM_000051.3	c.5948A>G	missense	-0.19	1.0	46.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase	rs659243		0.0 (ref)					1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle			0.00001	1118.67	A=3, G=82		A=2/1, G=49/33	2	
chr11:125525195	G/G	A	SNV		CHEK1	exonic	1								100.00	p.Ile471Val		212	A=0.0, G=1.0		Present				+	13	NM_001274.5	c.1411A>G	missense	0.45	1.0	29.0	0.0	Protein kinase domain,Protein tyrosine kinase	rs506504		0.017 (ref)	0.0363	0.0064	0.0262	YES	ATP binding,DNA damage checkpoint,DNA damage induced protein phosphorylation,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,G2/M transition of mitotic cell cycle,cell cycle,cell cycle checkpoint,cellular response to caffeine,cellular response to mechanical stimulus,cellular response to organic substance,centrosome,chromatin,chromatin-mediated maintenance of transcription,chromosome, telomeric region,condensed nuclear chromosome,cytoplasm,cytoskeleton,histone H3-T11 phosphorylation,histone kinase activity (H3-T11 specific),negative regulation of mitosis,nucleoplasm,nucleotide binding,nucleus,peptidyl-threonine phosphorylation,protein binding,protein serine/threonine kinase activity,regulation of S phase,regulation of double-strand break repair via homologous recombination,regulation of histone H3-K9 acetylation,regulation of mitotic centrosome separation,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,replication fork,replicative senescence,response to DNA damage stimulus	(2R)-1-(5,6-DIPHENYL-7H-PYRROLO2,3-DPYRIMIDIN-4-YL)AMINOPROPAN-2-OL,(2R)-3-{(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO2,3-DPYRIMIDIN-4-YLIDENEAMINO}PROPANE-1,2-DIOL,(2S)-1-AMINO-3-(5-NITROQUINOLIN-8-YL)AMINOPROPAN-2-OL,(3-ENDO)-8-METHYL-8-AZABICYCLO3.2.1OCT-3-YL 1H-PYRROLO2,3-BPYRIDINE-3-CARBOXYLATE,(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE,(5,6-DIPHENYL-FURO2,3-DPYRIMIDIN-4-YLAMINO)-ACETIC,(5-{3-5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL,1-(2S)-4-(5-BROMO-1H-PYRAZOLO3,4-BPYRIDIN-4-YL)MORPHOLIN-2-YLMETHANAMINE,1-(2S)-4-(5-phenyl-1H-pyrazolo3,4-bpyridin-4-yl)morpholin-2-ylmethanamine,1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-2-(DIMETHYLAMINO)-1-METHYLETHOXYPYRAZIN-2-YL}UREA,18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE,2,2'-{9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYLBIS(OXY)}DIACETIC ACID,2-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)AMINOETHANOL,2-(cyclohexylamino)benzoic acid,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,2-5,6-BIS-(4-METHOXY-PHENYL)-FURO2,3-DPYRIMIDIN-4-YLAMINO-ETHANOL,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,3-AMINO-3-BENZYL-4.3.0BICYCLO-1,6-DIAZANONAN-2-ONE,4-(3S)-1-AZABICYCLO2.2.2OCT-3-YLAMINO-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,4-(6-{(4-METHYLCYCLOHEXYL)AMINOMETHYL}-1,4-DIHYDROINDENO1,2-CPYRAZOL-3-YL)BENZOIC ACID,4-3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL-2-METHOXYPHENOL,4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl(phenyl)methanone,5,6,7,8-TETRAHYDRO1BENZOTHIENO2,3-DPYRIMIDIN-4(3H)-ONE,5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO4,3-CQUINOLIN-4-ONE,6-MORPHOLIN-4-YL-9H-PURINE,N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-1,3THIAZOLO5,4-CAZEPIN-2-YL)ACETAMIDE,N-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)GLYCINE,N-{5-4-(4-METHYLPIPERAZIN-1-YL)PHENYL-1H-PYRROLO2,3-BPYRIDIN-3-YL}NICOTINAMIDE,REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO1,2,3-FG:3',2',1'-KLPYRROLO3,4-I1,6BENZODIAZOCINE-1,3(2H)-DIONE		0.00001	3150.07	A=0, G=212		A=0/0, G=101/111	1	
chr12:25380253	C/T	C	SNV		KRAS	exonic	1								6.98	p.Asp69Asn		43	C=0.9302, T=0.0698		Present				-	3	NM_033360.3	c.205G>A	missense	2.89	0.02	23.0	0.194	Miro-like protein,Ras family								GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior	(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE		0.0517	12.8654	C=40, T=3		C=18/22, T=2/1	3	
chr12:25398284	CC/AC	CC	SNV		KRAS	exonic	1					HS	COSM520;COSM522;COSM521;COSM512;COSM514;COSM34144;COSM25081;COSM13643		AA=0.00, AC=26.09, AG=0.00, AT=0.00, GC=0.00, TA=0.00, TC=0.00, TT=0.00	p.Gly12Val		23	CC=0.7391, AA=0.0, AC=0.2609, AG=0.0, AT=0.0, GC=0.0, TA=0.0, TC=0.0, TT=0.0		Present				-	2	NM_033360.3	c.35G>T	missense	2.67,2.67	0.01	109.0	0.999	Miro-like protein,Ras family	rs121913529,rs121913530							GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior	(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE	other	0.00034	34.7449	CC=17, AA=0, AC=6, AG=0, AT=0, GC=0, TA=0, TC=0, TT=0		CC=9/8, AA=0/0, AC=2/4, AG=0/0, AT=0/0, GC=0/0, TA=0/0, TC=0/0, TT=0/0	2,2,2,2,2,2,2,2	
chr12:133219831	T/C	T	SNV		POLE	exonic	1								68.42	p.(=)		38	T=0.3158, C=0.6842		Present				-	35	NM_006231.3	c.4530A>G	synonymous	-2.11				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744944		0.416 (ref)	0.4306	0.2985	0.4776	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	302.627	T=12, C=26		T=4/8, C=15/11	1	
chr12:133236000	C/T	C	SNV		POLE	exonic	1								58.25	p.(=)		1449	C=0.4175, T=0.5825		Present				-	26	NM_006231.3	c.3156G>A	synonymous	-3.0				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744857		0.416 (ref)	0.4307	0.2985	0.4775	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	8659.45	C=605, T=844		C=372/233, T=512/332	1	
chr12:133241996	T/C	T	SNV		POLE	exonic	1								12.00	p.Asp787Gly		25	T=0.88, C=0.12		Present				-	21	NM_006231.3	c.2360A>G	missense	2.16	0.21	94.0	0.763	DNA polymerase family B,Domain of unknown function (DUF1744)								DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.03569	14.474	T=22, C=3		T=13/9, C=2/1	1	
chr13:28608028	C/T	C	SNV		FLT3	exonic	1								5.56	p.(=)		54	C=0.9444, T=0.0556		Present				-	15	NM_004119.2	c.1938G>A	synonymous	0.34				Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,cell surface,cellular response to cytokine stimulus,cytokine receptor activity,cytokine-mediated signaling pathway,endoplasmic reticulum,endoplasmic reticulum lumen,hemopoiesis,integral to plasma membrane,lymphocyte differentiation,membrane,myeloid progenitor cell differentiation,negative regulation of B cell differentiation,negative regulation of cell proliferation,nucleotide binding,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tyrosine phosphorylation of STAT protein,pro-B cell differentiation,pro-T cell differentiation,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of apoptotic process,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity	Sorafenib,Sunitinib		0.08933	10.49	C=51, T=3		C=23/28, T=1/2	1	
chr13:28636084	A/A	G	SNV		FLT3	exonic	1								100.00	p.(=)		552	G=0.0, A=1.0		Present				-	3	NM_004119.2	c.288C>T	synonymous	0.04				Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7338903		0.041 (ref)	0.0105	0.0978	0.0401	YES	ATP binding,cell surface,cellular response to cytokine stimulus,cytokine receptor activity,cytokine-mediated signaling pathway,endoplasmic reticulum,endoplasmic reticulum lumen,hemopoiesis,integral to plasma membrane,lymphocyte differentiation,membrane,myeloid progenitor cell differentiation,negative regulation of B cell differentiation,negative regulation of cell proliferation,nucleotide binding,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tyrosine phosphorylation of STAT protein,pro-B cell differentiation,pro-T cell differentiation,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of apoptotic process,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity	Sorafenib,Sunitinib		0.00001	8392.84	G=0, A=552		G=0/0, A=279/273	1	
chr13:32906729	A/C	A	SNV		BRCA2	exonic	1								23.47	p.Asn372His		277	A=0.7653, C=0.2347		Present				+	10	NM_000059.3	c.1114A>C	missense	-0.15	0.15	68.0	0.023	BRCA2 repeat	rs144848		0.24 (ref)	0.2859	0.1289	0.2332	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		non-pathogenic,other	0.00001	372.093	A=212, C=65		A=81/131, C=21/44	3	
chr13:32913055	G/G	A	SNV		BRCA2	exonic	1								100.00	p.(=)		332	A=0.0, G=1.0		Present				+	11	NM_000059.3	c.4563A>G	synonymous	0.6				BRCA2 repeat	rs206075		0.026 (ref)	6.0E-4	0.0704	0.0242	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	4947.19	A=0, G=332		A=0/0, G=152/180	1	
chr13:32915005	C/C	G	SNV		BRCA2	exonic	1								100.00	p.(=)		471	G=0.0, C=1.0		Present				+	11	NM_000059.3	c.6513G>C	synonymous	-1.1				BRCA2 repeat	rs206076		0.026 (ref)	6.0E-4	0.0713	0.0245	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	7157.82	G=0, C=471		G=0/0, C=262/209	1	
chr13:32929387	C/C	T	SNV		BRCA2	exonic	1								100.00	p.Val2466Ala		167	T=0.0, C=1.0		Present				+	14	NM_000059.3	c.7397T>C	missense	1.27	0.58	64.0	0.0	BRCA2 repeat	rs169547		0.022 (ref)	6.0E-4	0.0647	0.0223	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		untested	0.00001	2454.02	T=0, C=167		T=0/0, C=74/93	1	
chr14:105239894	C/T	C	SNV		AKT1	exonic	1								37.93	p.(=)		29	C=0.6207, T=0.3793		Present				-	9	NM_001014431.1	c.726G>A	synonymous	2.2				PH domain,Protein kinase C terminal domain,Protein kinase domain,Protein tyrosine kinase	rs1130233		0.314 (ref)	0.2459	0.1151	0.2016	YES	ATP binding,G-protein coupled receptor signaling pathway,RNA metabolic process,T cell costimulation,activation of pro-apoptotic gene products,activation-induced cell death of T cells,anti-apoptosis,apoptotic process,blood coagulation,carbohydrate metabolic process,carbohydrate transport,cell differentiation,cell proliferation,cellular response to insulin stimulus,cytoplasm,cytosol,endocrine pancreas development,enzyme binding,fibroblast growth factor receptor signaling pathway,identical protein binding,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular signal transduction,kinase activity,mRNA metabolic process,mammary gland epithelial cell differentiation,membrane fraction,microtubule cytoskeleton,multicellular organismal development,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of fatty acid beta-oxidation,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of protein kinase activity,negative regulation of release of cytochrome c from mitochondria,nerve growth factor receptor signaling pathway,nervous system development,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric-oxide synthase regulator activity,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,phosphatidylinositol-3,4,5-trisphosphate binding,phosphatidylinositol-3,4-bisphosphate binding,phosphatidylinositol-mediated signaling,phosphorylation,plasma membrane,platelet activation,positive regulation of anti-apoptosis,positive regulation of blood vessel endothelial cell migration,positive regulation of cell growth,positive regulation of cellular protein metabolic process,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of establishment of protein localization in plasma membrane,positive regulation of fat cell differentiation,positive regulation of glucose import,positive regulation of glucose metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of lipid biosynthetic process,positive regulation of nitric oxide biosynthetic process,positive regulation of nitric-oxide synthase activity,positive regulation of peptidyl-serine phosphorylation,positive regulation of protein phosphorylation,positive regulation of sequence-specific DNA binding transcription factor activity,protein autophosphorylation,protein binding,protein import into nucleus, translocation,protein kinase activity,protein modification process,protein phosphorylation,protein serine/threonine kinase activity,regulation of G1/S transition checkpoint,regulation of cell migration,regulation of glycogen biosynthetic process,regulation of neuron projection development,regulation of nitric-oxide synthase activity,regulation of translation,response to UV-A,response to fluid shear stress,response to heat,signal transduction,transport	5-(5-chloro-7H-pyrrolo2,3-dpyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo4,5-cpyridine,Adenosine triphosphate,Arsenic trioxide,Inositol 1,3,4,5-Tetrakisphosphate,N-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl-7H-pyrrolo2,3-dpyrimidin-4-amine		0.00001	85.7387	C=18, T=11		C=10/8, T=5/6	1	
chr15:89803950	C/T	C	SNV		FANCI	exonic	1								47.78	p.Pro55Leu		676	C=0.5222, T=0.4778		Present				+	4	NM_001113378.1	c.164C>T	missense	2.62	0.0	98.0	1.0		rs62020347		0.032 (ref)	0.0678	0.0234	0.0528	YES	DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	2954.84	C=353, T=323		C=154/199, T=120/203	5	
chr15:89838236	A/A	G	SNV		FANCI	exonic	1								100.00	p.(=)		842	G=0.0, A=1.0		Present				+	24	NM_001113378.1	c.2547G>A	synonymous	0.3					rs7183618		0.027 (ref)	0.0535	0.0087	0.0399	YES	DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	12620.0	G=0, A=842		G=0/0, A=421/421	2	
chr16:3639139	G/G	A	SNV		SLX4	exonic	1								98.89	p.(=)		90	A=0.0111, G=0.9889		Present				-	12	NM_032444.2	c.4500T>C	synonymous	0.83				BTB/POZ domain	rs3810812		0.306 (ref)	0.4923	0.1406	0.3734	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	1262.36	A=1, G=89		A=1/0, G=34/55	1	
chr16:3656482	C/T	C	SNV		SLX4	exonic	1								33.05	p.(=)		236	C=0.6695, T=0.3305		Present				-	3	NM_032444.2	c.753G>A	synonymous	-3.47				BTB/POZ domain	rs8061528		0.25 (ref)	0.203	0.2501	0.2189	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	573.362	C=158, T=78		C=63/95, T=27/51	4	
chr16:3656678	G/A	G	SNV		SLX4	exonic	1								5.62	p.Ser186Phe		89	G=0.9438, A=0.0562		Present				-	3	NM_032444.2	c.557C>T	missense	0.62	0.0	155.0	0.94	BTB/POZ domain								3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.0576	12.3961	G=84, A=5		G=33/51, A=2/3	3	
chr16:3777836	T/C	T	SNV		CREBBP	exonic	1								64.10	p.(=)		39	T=0.359, C=0.641		Present				-	31	NM_004380.2	c.7212A>G	synonymous	2.16				Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger	rs55916120		0.013 (ref)	0.0256	0.005	0.0186	YES	MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE		0.00001	282.682	T=14, C=25		T=9/5, C=6/19	2	
chr16:3860736	A/G	A	SNV		CREBBP	exonic	1								5.88	p.(=)		68	A=0.9412, G=0.0588		Present				-	3	NM_004380.2	c.843T>C	synonymous	0.85				Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger								MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE		0.06182	12.0886	A=64, G=4		A=38/26, G=2/2	1	
chr16:89866043	T/C	T	SNV		FANCA	exonic	1								70.28	p.Thr266Ala		609	T=0.2972, C=0.7028		Present				-	9	NM_000135.2	c.796A>G	missense	0.38	1.0	58.0	0.0	Fanconi anaemia group A protein	rs7190823		0.343 (ref)	0.3937	0.2743	0.494	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	4903.77	T=181, C=428		T=67/114, C=173/255	1	
chr17:7574000	C/A	C	SNV		TP53	exonic	1	Deleterious	Loss-of-function						44.00	p.Glu343Ter		225	C=0.56, A=0.44		Present				-	10	NM_000546.5	c.1027G>T	nonsense	0.03				P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif	rs375573770			0.0	2.0E-4	1.0E-4		ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine		0.00001	859.033	C=126, A=99		C=51/75, A=49/50	1	
chr17:7579472	G/C	G	SNV		TP53	exonic	1								86.70	p.Pro72Arg		218	G=0.133, C=0.867		Present				-	4	NM_000546.5	c.215C>G	missense	1.36	0.6	103.0	0.083	P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif	rs1042522		0.398 (ref)	0.2548	0.4051	0.37	YES	ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	non-pathogenic	0.00001	2473.42	G=29, C=189		G=4/25, C=85/104	6	
chr17:29508775	A/A	G	SNV		NF1	exonic	1								100.00	p.(=)		27	G=0.0, A=1.0		Present				+	7	NM_001042492.2	c.702G>A	synonymous	-3.81				GTPase-activator protein for Ras-like GTPase	rs1801052		0.45 (ref)	0.2899	0.3098	0.4256	YES	MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing			0.00001	375.679	G=0, A=27		G=0/0, A=22/5	1	
chr17:29664526	G/A	G	SNV		NF1	exonic	1								3.08	p.Gly2190Ser		65	G=0.9683, A=0.0317		Present				+	43	NM_001042492.2	c.6568G>A	missense	2.7	0.6	56.0	0.069	GTPase-activator protein for Ras-like GTPase								MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing			0.08301	10.8087	G=61, A=2		G=32/29, A=1/1	2	
chr17:33446143	C/T	C	SNV		RAD51D,RAD51L3-RFFL	intronic_nc, exonic, exonic, exonic, exonic_nc, exonic_nc	1								6.12	p.Gly44Asp, p.Gly44Asp, p.Gly44Asp		49	C=0.9388, T=0.0612		Present				-	2	NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1	c.131G>A, c.131G>A, c.131G>A	missense, missense, missense	2.6		94.0, 94.0, 94.0			rs374730714			1.0E-4	0.0	1.0E-4		ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination			0.07055	11.5148	C=46, T=3		C=19/27, T=1/2	2	
chr17:41223094	T/C	T	SNV		BRCA1	exonic	1								36.59	p.Ser1634Gly		369	T=0.6341, C=0.3659		Present				-	16	NM_007300.3	c.4900A>G	missense	0.13	0.03	56.0	0.58	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799966		0.327	0.3266	0.2426	0.2982	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	1032.07	T=234, C=135		T=135/99, C=61/74	1	
chr17:41234420	C/T	C	SNV		BRCA1	splicesite_3	1					HS	MCH45		5.94			101	C=0.9406, T=0.0594		Present				-	12	NM_007300.3			2.75				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs80358027		0.0					BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		pathogenic	0.09149	10.3863	C=95, T=6		C=43/52, T=5/1	2	
chr17:41234470	A/G	A	SNV		BRCA1	exonic	1								41.78	p.(=)		450	A=0.5822, G=0.4178		Present				-	12	NM_007300.3	c.4308T>C	synonymous	0.13				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1060915		0.304 (ref)	0.326	0.1888	0.2796	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	1563.79	A=262, G=188		A=123/139, G=107/81	2	
chr17:41244000	T/C	T	SNV		BRCA1	exonic	1								45.31	p.Lys1183Arg		128	T=0.5469, C=0.4531		Present				-	10	NM_007300.3	c.3548A>G	missense	-0.44	1.0	26.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16942,rs80357956		0.324 (ref)	0.3244	0.2383	0.2952	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	494.699	T=70, C=58		T=34/36, C=26/32	3	
chr17:41244435	T/C	T	SNV		BRCA1	exonic	1								34.38	p.Glu1038Gly		96	T=0.6563, C=0.3438		Present				-	10	NM_007300.3	c.3113A>G	missense	0.11	0.02	98.0	0.158	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16941,rs80357920		0.303 (ref)	0.3255	0.1884	0.279	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	240.13	T=63, C=33		T=32/31, C=13/20	2	
chr17:41244936	G/A	G	SNV		BRCA1	exonic	1								37.25	p.Pro871Leu		51	G=0.6275, A=0.3725		Present				-	10	NM_007300.3	c.2612C>T	missense	0.94	1.0	98.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs799917,rs80357962		0.483	0.3359	0.2	0.4932	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	141.603	G=32, A=19		G=18/14, A=15/4	2	
chr17:41245237	A/G	A	SNV		BRCA1	exonic	1								44.63	p.(=)		121	A=0.5537, G=0.4463		Present				-	10	NM_007300.3	c.2311T>C	synonymous	-0.83				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16940		0.302 (ref)	0.3237	0.1877	0.2776	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	465.133	A=67, G=54		A=33/34, G=16/38	2	
chr17:41245466	G/A	G	SNV		BRCA1	exonic	1								33.41	p.(=)		853	G=0.6659, A=0.3341		Present				-	10	NM_007300.3	c.2082C>T	synonymous	-0.08				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799949		0.324 (ref)	0.3244	0.2396	0.2957	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	2040.23	G=568, A=285		G=334/234, A=156/129	1	
chr17:41245471	C/T	C	SNV		BRCA1	exonic	1								33.84	p.Asp693Asn		851	C=0.6616, T=0.3384		Present				-	10	NM_007300.3	c.2077G>A	missense	0.13	0.05	23.0	0.001	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs4986850		0.039	0.0702	0.0232	0.0543	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	2103.66	C=563, T=288		C=329/234, T=159/129	1	
chr17:56435885	G/T	G	SNV		RNF43	exonic	1								27.01	p.Leu418Met		1270	G=0.7299, T=0.2701		Present				-	9	NM_017763.4	c.1252C>A	missense	2.18	0.0	15.0	0.948	Zinc finger	rs2526374		0.398 (ref)	0.3591	0.4024	0.3738	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	2155.72	G=927, T=343		G=509/418, T=191/152	1	
chr17:56492800	C/C	T	SNV		RNF43	exonic	1								100.00	p.Ile47Val		430	T=0.0, C=1.0		Present				-	2	NM_017763.4	c.139A>G	missense	0.97	0.1	29.0	0.001	Zinc finger	rs3744093		0.392 (ref)	0.3851	0.2174	0.3283	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	6490.56	T=0, C=430		T=0/0, C=212/218	1	
chr19:15271771	A/A	G	SNV		NOTCH3	exonic	1								100.00	p.Ala2223Val		743	G=0.0, A=1.0		Present				-	33	NM_000435.2	c.6668C>T	missense	0.08	0.18	64.0	0.001	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044009		0.368 (ref)	0.1987	0.397	0.2651	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	11263.5	G=0, A=743		G=0/0, A=361/382	1	
chr19:15278057	G/G	A	SNV		NOTCH3	splicesite_3	1								100.00			245	A=0.0, G=1.0		Present				-	29	NM_000435.2			0.62				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1548555		0.133 (ref)	0.1034	0.0236	0.0763	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	3639.27	A=0, G=245		A=0/0, G=127/118	2	
chr19:15285052	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		398	T=0.0, C=1.0		Present				-	25	NM_000435.2	c.4563A>G	synonymous	-1.43				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044006		0.133 (ref)	0.1002	0.0223	0.0739	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	6046.8	T=0, C=398		T=0/0, C=181/217	1	
chr19:15292437	T/C	T	SNV		NOTCH3	exonic	1								96.15	p.(=)		26	T=0.0385, C=0.9615		Present				-	17	NM_000435.2	c.2742A>G	synonymous	-4.38				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043997		0.233 (ref)	0.1299	0.3636	0.2095	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	330.58	T=1, C=25		T=1/0, C=16/9	1	
chr19:15302844	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		1996	T=0.0, C=1.0		Present				-	4	NM_000435.2	c.606A>G	synonymous	-2.59				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043994		0.144 (ref)	0.1224	0.0878	0.1107	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	30345.3	T=0, C=1996		T=0/0, C=874/1122	1	
chr20:36030939	C/C	G	SNV		SRC	exonic	1								100.00	p.(=)		62	G=0.0, C=1.0		Present				+	12	NM_198291.2	c.1218G>C	synonymous	-2.02				Protein kinase domain,Protein tyrosine kinase,SH2 domain,SH3 domain,Variant SH3 domain	rs1885257		0.012 (ref)					ATP binding,Ras protein signal transduction,SH2 domain binding,SH3/SH2 adaptor activity,T cell costimulation,axon guidance,blood coagulation,bone resorption,branching involved in mammary gland duct morphogenesis,caveola,cell adhesion,cell cycle,cell junction assembly,cellular membrane organization,cytoplasm,cytoskeleton,cytosol,ephrin receptor binding,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,forebrain development,heme binding,integrin binding,interspecies interaction between organisms,intracellular protein kinase cascade,ion channel binding,kinase activity,leukocyte migration,mitochondrial inner membrane,mitochondrion,nerve growth factor receptor signaling pathway,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,oogenesis,peptidyl-tyrosine phosphorylation,phosphorylation,plasma membrane,platelet activation,positive regulation of integrin activation,protein binding,protein kinase activity,protein phosphorylation,protein tyrosine kinase activity,receptor binding,regulation of bone resorption,regulation of intracellular estrogen receptor signaling pathway,regulation of vascular permeability,response to interleukin-1,signal complex assembly,signal transduction,uterus development	(2E)-N-{4-(3-bromophenyl)aminoquinazolin-6-yl}-4-(dimethylamino)but-2-enamide,1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo3,4-dpyrimidin-4-amine,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-naphthalen-1-ylurea,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-phenylurea,1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo3,4-dpyrimidin-4-amine,1-cyclopentyl-3-(1H-pyrrolo2,3-bpyridin-5-yl)-1H-pyrazolo3,4-dpyrimidin-4-amine,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,3-4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-3-YLPHENOL,4-(4-METHYL-1-PIPERAZINYL)METHYL-N-3-4-(3-PYRIDINYL)-2-PYRIMIDINYLAMINOPHENYL-BENZAMIDE,4-({4-(5-cyclopropyl-1H-pyrazol-3-yl)aminoquinazolin-2-yl}amino)phenylacetonitrile,Citric Acid,DPI59,Dasatinib,ISO24,Malonic acid,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,N6-Benzyl Adenosine-5'-Diphosphate,Oxalic Acid,PAS219,PASBN,Phenylphosphate,Phosphonotyrosine,Purvalanol A,RU78191,RU78262,RU78299,RU78300,RU78783,RU79072,RU79073,RU79256,RU81843,RU82129,RU82197,RU82209,RU83876,RU84687,RU85053,RU85493,RU90395		0.00001	895.507	G=0, C=62		G=0/0, C=32/30	2	
